138 related articles for article (PubMed ID: 36078941)
1. Real-Life Value of the Odysight
Kielwasser G; Kodjikian L; Dot C; Burillon C; Denis P; Mathis T
J Clin Med; 2022 Aug; 11(17):. PubMed ID: 36078941
[TBL] [Abstract][Full Text] [Related]
2. Home vision monitoring in patients with maculopathy: Real-life study of the OdySight application.
Guigou S; Michel T; Mérité PY; Coupier L; Meyer F
J Fr Ophtalmol; 2021 Jun; 44(6):873-881. PubMed ID: 34024655
[TBL] [Abstract][Full Text] [Related]
3. [Neovascular recurrences in 42 treatment-naive eyes with neovascular age-related macular degeneration (AMD) followed for over 2 years].
Bodénès F; Massé H; Lebreton O; Weber M
J Fr Ophtalmol; 2021 May; 44(5):626-631. PubMed ID: 33840491
[TBL] [Abstract][Full Text] [Related]
4. Odysight: A Mobile Medical Application Designed for Remote Monitoring-A Prospective Study Comparison with Standard Clinical Eye Tests.
Brucker J; Bhatia V; Sahel JA; Girmens JF; Mohand-Saïd S
Ophthalmol Ther; 2019 Sep; 8(3):461-476. PubMed ID: 31346977
[TBL] [Abstract][Full Text] [Related]
5. Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study.
Busch C; Fraser-Bell S; Zur D; Rodríguez-Valdés PJ; Cebeci Z; Lupidi M; Fung AT; Gabrielle PH; Giancipoli E; Chaikitmongkol V; Okada M; Laíns I; Santos AR; Kunavisarut P; Sala-Puigdollers A; Chhablani J; Ozimek M; Hilely A; Unterlauft JD; Loewenstein A; Iglicki M; Rehak M;
Acta Diabetol; 2019 Jul; 56(7):777-784. PubMed ID: 30903434
[TBL] [Abstract][Full Text] [Related]
6. Visual Outcomes after Anti-VEGF Therapy for Exudative Age-Related Macular Degeneration in a Real-Life Setting.
Wenkstern AR; Valmaggia C
Klin Monbl Augenheilkd; 2021 Apr; 238(4):396-402. PubMed ID: 33930919
[TBL] [Abstract][Full Text] [Related]
7. Is current age related macular degeneration self-monitoring a good tool for detecting exudative recurrence?
Chamard C; Lacombe S; Navarre S; Rohart C; Daures JP; Allieu S
J Fr Ophtalmol; 2019 Dec; 42(10):1049-1055. PubMed ID: 31727329
[TBL] [Abstract][Full Text] [Related]
8. Anti-vascular endothelial growth factor therapy in diabetic macular edema: real-life outcomes from a multicenter study in Turkey over 36 months.
Durukan AH; Unlu N; Onen M; Alp MN; Yeşiltaş YS; Kalayci D; Acar MA; Sekeroglu MA; Citirik M; Altintas AGK; Hazirolan D; Kucukevcilioglu M; Ozdal PC; Toklu Y; Bicer T; Ugurlu N; Budakoglu O; Yazar Z; Ucgun NI; Serdar K; Doguizi S; Erol YO; Atilgan CU; Yorgun MA; Soba DO; Berker N; Baskan C; Yilmaz ES
Int Ophthalmol; 2022 Dec; 42(12):3777-3787. PubMed ID: 35829865
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.
Banister K; Cook JA; Scotland G; Azuara-Blanco A; Goulão B; Heimann H; Hernández R; Hogg R; Kennedy C; Sivaprasad S; Ramsay C; Chakravarthy U
Health Technol Assess; 2022 Jan; 26(8):1-142. PubMed ID: 35119357
[TBL] [Abstract][Full Text] [Related]
10. Smartphone-based remote monitoring of vision in macular disease enables early detection of worsening pathology and need for intravitreal therapy.
Islam M; Sansome S; Das R; Lukic M; Chong Teo KY; Tan G; Balaskas K; Thomas PBM; Bachmann LM; Schimel AM; Sim DA
BMJ Health Care Inform; 2021 May; 28(1):. PubMed ID: 34035050
[TBL] [Abstract][Full Text] [Related]
11. Real-World Effectiveness and Real-World Cost-Effectiveness of Intravitreal Aflibercept and Intravitreal Ranibizumab in Neovascular Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Real-World Studies.
Carrasco J; Pietsch GA; Nicolas MP; Koerber C; Bennison C; Yoon J
Adv Ther; 2020 Jan; 37(1):300-315. PubMed ID: 31728825
[TBL] [Abstract][Full Text] [Related]
12. One-Year Outcome of Conbercept Therapy for Diabetic Macular Edema.
Li F; Zhang L; Wang Y; Xu W; Jiao W; Ma A; Zhao B
Curr Eye Res; 2018 Feb; 43(2):218-223. PubMed ID: 29265939
[TBL] [Abstract][Full Text] [Related]
13. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
Shalchi Z; Mahroo O; Bunce C; Mitry D
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
[TBL] [Abstract][Full Text] [Related]
14. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal Ranibizumab in Daily Clinical Practice for Age-Related Macular Degeneration: Treatment of Exudative Age-Related Macular Degeneration in Real Life.
Cazet-Supervielle A; Gozlan J; Cabasson S; Boissonnot M; Manic H; Leveziel N
Ophthalmologica; 2015; 234(1):26-32. PubMed ID: 26111575
[TBL] [Abstract][Full Text] [Related]
16. Current smoking is associated with a poor visual acuity improvement after intravitreal ranibizumab therapy in patients with exudative age-related macular degeneration.
Lee S; Song SJ; Yu HG
J Korean Med Sci; 2013 May; 28(5):769-74. PubMed ID: 23678271
[TBL] [Abstract][Full Text] [Related]
17. FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and relatively good baseline visual acuity.
Monés J; Biarnés M; Trindade F; Casaroli-Marano R
Graefes Arch Clin Exp Ophthalmol; 2012 Dec; 250(12):1737-44. PubMed ID: 22527314
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated with Recurrence of Age-Related Macular Degeneration after Anti-Vascular Endothelial Growth Factor Treatment: A Retrospective Cohort Study.
Kuroda Y; Yamashiro K; Miyake M; Yoshikawa M; Nakanishi H; Oishi A; Tamura H; Ooto S; Tsujikawa A; Yoshimura N
Ophthalmology; 2015 Nov; 122(11):2303-10. PubMed ID: 26271842
[TBL] [Abstract][Full Text] [Related]
19. Treatment of exudative age-related macular degeneration with intravitreal ranibizumab in clinical practice: a 3-year follow-up.
Marques IP; Fonseca P; Luz Cachulo M; Pires I; Figueira J; Faria de Abreu JR; Silva R
Ophthalmologica; 2013; 229(3):158-67. PubMed ID: 23485818
[TBL] [Abstract][Full Text] [Related]
20. Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration.
Nguyen V; Daien V; Guymer R; Young S; Hunyor A; Fraser-Bell S; Hunt A; Gillies MC; Barthelmes D;
Ophthalmology; 2019 Jan; 126(1):64-74. PubMed ID: 30149035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
